Brian I. Carr
Liver Cancer Center
Thomas E. Starzl Transplant Institute
University of Pittsburgh
Pittsburgh
USA
Name/email consistency: high
- Hepatic arterial 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients. Carr, B.I. Liver Transpl. (2004)
- A Cdc25A antagonizing K vitamin inhibits hepatocyte DNA synthesis in vitro and in vivo. Carr, B.I., Wang, Z., Wang, M., Kar, S., Wilcox, C.S., Rosi, K., Southwick, E., Lazo, J.S. J. Mol. Biol. (2003)
- To transplant, or not to transplant?. Carr, B.I., Marsh, J.W., Geller, D.A. Liver Transpl. (2003)
- Hepatic artery chemoembolization for advanced stage HCC: experience of 650 patients. Carr, B.I. Hepatogastroenterology (2002)
- K vitamins, PTP antagonism, and cell growth arrest. Carr, B.I., Wang, Z., Kar, S. J. Cell. Physiol. (2002)
- Effects of cisplatin dose intensity on response and survival for patients with unresectable and untransplantable hepatocellular carcinoma: an analysis of 57 patients. Carr, B.I., Dvorchik, I. Gan. To. Kagaku. Ryoho (2000)